Current Price Status
Stock is in Momentum
Stock is currently overvalued by the market with the expectation of annual earning growth at 210% to match current price.
Overvalued stock can be traded very volatile. If the earning growth momentum continue, overvalued stock can match into fair value, on the flip side, the downside risk can be huge if the stock is not meeting the market expectation.
Company is not in Profit
- MGRC current price is INF% above OneDelta estimated fair value.
The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.
Relative Price Performance
OutperformedMGRC past 5-day return perform better than Commercial Services industry average return by 5.85%
Above 30-Day AverageCurrent price RM1.86 is above than 30-day average RM1.58 by 17.7%
|Return (%)||MGRC||Commercial Services|
Bank Analyst Price Targets
Revenue & Earning Growth Analysis
Recent Positive Revenue Growth
MGRC managed to achieve better revenue growth for past 2 quarters by average +1428%.
Continued Losing Money
MGRC has been losing money in the 4 of the past 5 quarters.
Past Quarter Reports
|Quarter Date||Revenue (RM)||(%)||EPS (RM)||(%)|
Volume Trend Analysis
Recent Volume is Increasing
Surge in trading volume tends to bring more price volatility in near term.
MGRC recent daily traded volume is 36.76% higher than past month average.
|Past 30-Day||Past 5-Day|
|68k daily||93k daily|
Price History Chart
Past 30-day Average Price: RM1.58
Stock Fundamental Factors
Fundamental factor characteristics help us understand and expect how the stock price will behave in short and long term.
Stocks that has more than two consecutive money-losing quarters
Stock Thematic Baskets
Usually the more the stock is included in popular themes, the more opportunity for price-driven momentum and better liquidity.
Stock Company Profile
MSIAN GENOMICS RES CENTRE BHD
Malaysian Genomics Resource Centre Bhd. is an investment holding company, which engages in the provision of laboratory services. It focuses on the genome sequencing and analysis, genetic screening services, and pathology services. The company was founded by Robert George Hercus and Munirah binti Haji Abdul Hamid on May 18, 2004 and is headquartered in Kuala Lumpur, Malaysia.